Rationalizing the therapeutic potential of apigenin against cancer
| Autor: | Dey Parama, Semim Akhtar Ahmed, Ajaikumar B. Kunnumakkara, Uma Dutta, Kishore Banik, Choudhary Harsha, Enush Daimari, Sosmitha Girisa |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Biological Availability Disease 030226 pharmacology & pharmacy General Biochemistry Genetics and Molecular Biology 03 medical and health sciences chemistry.chemical_compound Phosphatidylinositol 3-Kinases 0302 clinical medicine Radioresistance Neoplasms medicine Humans General Pharmacology Toxicology and Pharmaceutics Apigenin Adverse effect PI3K/AKT/mTOR pathway Biological Products TOR Serine-Threonine Kinases Wnt signaling pathway NF-kappa B Cancer General Medicine medicine.disease 030104 developmental biology chemistry Cancer cell Cancer research Proto-Oncogene Proteins c-akt Signal Transduction |
| Zdroj: | Life sciences. 267 |
| ISSN: | 1879-0631 |
| Popis: | Background Despite the remarkable advances made in the diagnosis and treatment of cancer during the past couple of decades, it remains the second largest cause of mortality in the world, killing approximately 9.6 million people annually. The major challenges in the treatment of the advanced stage of this disease are the development of chemoresistance, severe adverse effects of the drugs, and high treatment cost. Therefore, the development of drugs that are safe, efficacious, and cost-effective remains a ‘Holy Grail’ in cancer research. However, the research over the past four decades shed light on the cancer-preventive and therapeutic potential of natural products and their underlying mechanism of action. Apigenin is one such compound, which is known to be safe and has significant potential in the prevention and therapy of this disease. Aim To assess the literature available on the potential of apigenin and its analogs in modulating the key molecular targets leading to the prevention and treatment of different types of cancer. Method A comprehensive literature search has been carried out on PubMed for obtaining information related to the sources and analogs, chemistry and biosynthesis, physicochemical properties, biological activities, bioavailability and toxicity of apigenin. Key findings The literature search resulted in many in vitro, in vivo and a few cohort studies that evidenced the effectiveness of apigenin and its analogs in modulating important molecular targets and signaling pathways such as PI3K/AKT/mTOR, JAK/STAT, NF-κB, MAPK/ERK, Wnt/β-catenin, etc., which play a crucial role in the development and progression of cancer. In addition, apigenin was also shown to inhibit chemoresistance and radioresistance and make cancer cells sensitive to these agents. Reports have further revealed the safety of the compound and the adaptation of nanotechnological approaches for improving its bioavailability. Significance Hence, the present review recapitulates the properties of apigenin and its pharmacological activities against different types of cancer, which warrant further investigation in clinical settings. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect